Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 840 | 838 | 688 | 683 | 702 |
| Accounts receivable | 2,228 | -4,986 | -5,600 | -5,397 | -3,231 |
| Accounts payable and accrued liabilities | 462 | -6,704 | N/A | 118 | 8,134 |
| Other Working Capital | -4,248 | -18,491 | -1,763 | -11,679 | 1,369 |
| Other Operating Activity | -27,153 | -17,403 | -19,247 | -23,975 | -44,953 |
| Operating Cash Flow | $-27,871 | $-46,746 | $-25,922 | $-40,250 | $-37,979 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -79 | -35 | 96 | -222 |
| Purchase Of Investment | -69,451 | -163,504 | -96,127 | -125,844 | -101,819 |
| Sale Of Investment | 115,111 | 110,566 | 90,675 | 99,101 | 103,711 |
| Purchase Sale Intangibles | 0 | 0 | 0 | -159 | 0 |
| Other Investing Activity | -39 | 0 | 0 | -6,000 | 0 |
| Investing Cash Flow | $45,621 | $-53,017 | $-5,487 | $-32,806 | $1,670 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 196,740 | N/A | N/A |
| Other Financing Activity | 1,340 | 405 | 8,982 | 9,082 | 1,279 |
| Financing Cash Flow | $1,340 | $405 | $205,722 | $9,082 | $1,279 |
| Beginning Cash Position | 132,542 | 231,900 | 57,587 | 121,561 | 156,591 |
| End Cash Position | 151,632 | 132,542 | 231,900 | 57,587 | 121,561 |
| Net Cash Flow | $19,090 | $-99,358 | $174,313 | $-63,974 | $-35,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,871 | -46,746 | -25,922 | -40,250 | -37,979 |
| Capital Expenditure | N/A | -79 | -35 | -63 | -222 |
| Free Cash Flow | -27,871 | -46,825 | -25,957 | -40,313 | -38,201 |